hypercoagulability – Page 14 – Communicable Diseases Research

Platelets and renal failure in the SARS-CoV-2 syndrome

SARS-CoV-2 증후군의 혈소판 및 신부전

Article

Published on 2021-01-022022-09-12
Journal: Platelets [Category] SARS, 진단,

Complement activation and endothelial perturbation parallel COVID-19 severity and activity

보완 활성화 및 내피 교란은 COVID-19 심각도 및 활동과 병행합니다.

Article

Published on 2021-01-012022-08-31
Journal: Journal of autoimmunity [Category] MERS, SARS, 바이오마커,

[키워드] Activation animal animal models association Biomarker Biomarkers C5a cohort study complement Complement activation complement system contribute coronavirus coronavirus disease coronavirus disease-2019 correlated COVID-19 COVID-19 patients COVID-19 severity disease severity endothelial endothelial damage endotheliopathy Endothelium evaluate evaluated high plasma level high plasma levels Hospital admission hypercoagulability manifestation Mild moderate pathophysiology Patient patients with COVID-19 plasma progression Remission SC5b-9 selectin severe disease severity significantly significantly increased target the disease the patient therapy tissue injury von Willebrand factor were measured
[DOI] 10.1016/j.jaut.2020.102560 PMC 바로가기 [Article Type] Article

A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients

입원한 코로나19 환자 173명을 대상으로 한 항인지질항체 유병률, 혈전성 질환, 혈관병증 피부 징후에 대한 후향적 연구

Article

Published on 2021-01-012022-09-12
Journal: International journal of immunopathology and pharm [Category] MERS, 진단,

[키워드] acrocyanosis adjusted affecting analyzed Anti-phospholipid antibodies anti-phospholipid syndrome antibodies antibody Artery association COVID-19 COVID-19 patients COVID-19 severity cutaneous manifestation enrolled event events hospitalized COVID-19 patient hypercoagulability Hypercoagulation involved Ischemia livedo reticularis manifestation Mortality nine not correlated occurred Patient patients patients with COVID-19 Prevalence pulmonary embolisms responsible Retrospective study risk factor SARS-CoV-2 serum sample syndrome the patient Thromboembolic event Thromboembolic events thrombosis thrombotic event Typical Vascular Vasculopathy
[DOI] 10.1177/20587384211042115 PMC 바로가기 [Article Type] Article

Cerebral Venous Thrombosis Associated with COVID-19 Infection: An Observational, Multicenter Study

Observational Study

Published on 2021-01-012022-10-05
Journal: Cerebrovascular diseases extra [Category] 임상,

[키워드] Admission age association C-reactive protein cerebral Cerebral venous thrombosis cerebrovascular diseases Coagulopathy Coronavirus disease 2019 country COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients D-dimer discharge elevated erythrocyte sedimentation rate functional headache hemorrhage homocysteine hypercoagulability identify Infarction Inflammatory marker male male-to-female ratio men mortality rate multicenter multicenter study neurological Older age outcome participated Patient patients presenting presenting symptoms raised reported respiratory risk factor scale Seizure Seizures serum Singapore stroke surviving patients Survivors Symptom symptomatic tested Thromboembolism thrombosis treated United Arab Emirates venous Venous thrombosis with COVID-19
[DOI] 10.1159/000516641 PMC 바로가기 [Article Type] Observational Study

Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose

당뇨병이 있거나 없는 COVID-19 환자 및 공복 혈당 장애 환자에서 증가된 피브리노겐의 결정 요인

Article

Published on 2021-01-012022-09-11
Journal: Clinical and applied thrombosis/hemostasis : offic [Category] 바이오마커,

[키워드] analyzed C-reactive protein control group COVID-19 COVID-19 patient COVID-19 patients CRP demographic data determinant diabete diabetes died elevated Factor fasting fasting glucose ferritin ferritin levels fibrinogen Final Glucose glucose metabolism group Hospitalization hypercoagulability IL-6 IL-8 Impaired impaired fasting glucose Increased Inflammation insulin insulin resistance interleukin interleukin-6 involved IQR Laboratory results Linear regression medical history metabolism Multiple Multiple linear regression Necrosis normal range Patient positively correlated R 2 reduce Regulation Serum ferritin significantly increased Signs and symptoms Symptoms TG level TG levels TNF-α Triglyceride triglycerides Tumor tumor necrosis tumor necrosis factor tumor necrosis factor-α was impaired
[DOI] 10.1177/1076029621996445 PMC 바로가기 [Article Type] Article

Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients

Research Article

Published on 2021-01-012022-10-28
Journal: Acta Naturae [Category] COVID-19,

Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target

Review

Published on 2020-12-282022-10-04
Journal: International immunopharmacology [Category] SARS, 신약개발, 치료법,

[키워드] Abstract activities acute respiratory syndrome Anti-inflammatory antiapoptotic antioxidant antiplatelet CAMP Cardioprotective cause Cilostazol complications coronavirus coronavirus disease COVID-19 COVID-19 severity Cytokine storm drug Effects elevated ENhance evaluated events FDA-approved drug glycoprotein highlight hypercoagulability hyperinflammation Hypothesis immune response Inflammatory inhibit inhibiting inhibitor Lungs M pro main mechanisms molecular pathophysiology pharmacological Pleiotropic effects poor prognosis promote protease raise SARS-CoV-2 Scientific community selective spike Spread Support target target proteins the disease Therapeutic approach therapeutic target thinking Treatment Viral pneumonia Virtual screening
[DOI] 10.1016/j.intimp.2020.107336 PMC 바로가기 [Article Type] Review

Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review

Case Report

Published on 2020-12-222022-10-27
Journal: BMC Geriatrics [Category] COVID-19,

Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review

Case Report

Published on 2020-12-222022-10-27
Journal: BMC Geriatrics [Category] Coronavirus, COVID-19, MERS, SARS,

Coronavirus-induced coagulopathy during the course of disease

질병 경과 중 코로나바이러스 유발 응고병증

Research Article

Published on 2020-12-172022-08-13
Journal: PLoS ONE [Category] Biochemistry, MERS, SARS, 바이오마커, 진단,

[키워드] Activation Administered adult COVID-19 patient adverse outcome age alteration Analysis analyzed anticoagulation Antithrombotic argatroban change Coagulation Coagulopathy comparable coronavirus coronavirus disease Course COVID-19 COVID-19 patient COVID-19 patients D-dimer D-dimer level D-dimer levels D-dimers decrease diagnosed disease elevated event fibrinogen fibrinogen level heparin heparin-induced thrombocytopenia Hospitalized hypercoagulability ICU incidence increased risk intensive care intensive care unit treatment investigated Laboratory low-molecular-weight-heparin male marker mean value observation period outpatients Patient patients died patients treated peak levels Platelet count Prophylaxis proportion prothrombin Prothrombin time receiving required Result retrospective Sensitivity analyses sensitivity analysis significant decrease single-center subsequent Switzerland the disease thrombin thrombin time thrombocytopenia thromboembolic Thromboembolic event Thromboembolic events Thromboembolism Treatment two patients unfractionated heparin university venous ward
[DOI] 10.1371/journal.pone.0243409 PMC 바로가기 [Article Type] Research Article